Early Clinical Development

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the meeting, please visit us to learn more about QPS’ range of services. We have supported gene therapy since 2002: ASOs, siRNAs, miRNA through mRNAs and viral vectors utilizing LC-HRMS, hybridization-LC, and

QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference Read More »

lantern

Spreading Early Clinical Knowledge

Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature. Learn more by reading: A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single

Spreading Early Clinical Knowledge Read More »

Scroll to Top